PCV79 Economic Evaluation of Rosuvastatin Versus Atorvastatin, Simvastatin and Pravastatin in High Risk Patients Treated for Primary and Secondary Prevention of Cardiovascular Disease in Greece
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.799
https://www.valueinhealthjournal.com/article/S1098-3015(11)02361-8/fulltext
Title :
PCV79 Economic Evaluation of Rosuvastatin Versus Atorvastatin, Simvastatin and Pravastatin in High Risk Patients Treated for Primary and Secondary Prevention of Cardiovascular Disease in Greece
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02361-8&doi=10.1016/j.jval.2011.08.799
First page :
A378
Section Title :
Cardiovascular Disorders
Open access? :
No
Section Order :
767